IntangiriroObesity ikomeje kuba imwe mu mbogamizi zikomeye ku buzima ku isi, ifitanye isano n'indwara zidakira nka diyabete, indwara z'umutima n'imitsi, na kanseri zimwe. Soma Ibikurikira

Intangiriro Imiterere yimiti igabanya ibiro irahinduka vuba, itanga ibyiringiro kubantu bahanganye numubyibuho ukabije hamwe nubuzima bwa metabolike. Ibiyobyabwenge bitatu byakuruye cyane: Retatrutid, Semaglutid (Ozempic / Wegovy), na Tirzepatid (Mounjaro / Zepbound). Soma Ibikurikira

IriburiroMu myaka yashize, ikiganiro cyisi yose kijyanye no gucunga ibiro no kuvura umubyibuho ukabije cyahindutse cyane. Ubuvuzi bwubuvuzi bwagiye busunika imbibi zishoboka, burenze inama zubuzima nubuvuzi bwibanze bugana ku buvuzi buhanitse, butandukanye. Soma Ibikurikira

Imiti ya GLP-1, harimo imiti nka semaglutide na liraglutide, ni icyiciro cyibiyobyabwenge bigana imisemburo isanzwe ya GLP-1 igenga isukari yamaraso no gucunga ubushake bwo kurya. Iyi miti igira akamaro kanini mu kuvura diyabete yo mu bwoko bwa 2 mu kongera imisemburo ya insuline, ikabuza glucagon gusohora, no kunoza igenzura ry’amaraso muri rusange. Bemerewe kandi na FDA kugabanya ibiro mu gucunga umubyibuho ukabije, bifasha abarwayi kugabanya inzara no guteza imbere ibinure. Nubwo muri rusange umutekano, urashobora gutera ingaruka zimwe na zimwe nka gastrointestinal. Hamwe ningaruka zikomeye kubuzima bwa metabolike, GLP-1 reseptor agonist nigikoresho cyingenzi muri diyabete igezweho no kuvura umubyibuho ukabije. Soma Ibikurikira

GLP-1 reseptor agonist, nka semaglutide, liraglutide, na exenatide, ni imiti ifatika yo kugabanya ibiro. Semaglutid iragaragara kubera ingaruka zayo zikomeye zo kugabanya ibiro, abarwayi bagabanuka kugera kuri 15% byuburemere bwumubiri mugihe cyo kwa muganga. Liraglutide irerekana kandi ibisubizo bitanga icyizere, nubwo ingaruka zayo ari nto. Exenatide na dulaglutide, nubwo ari ingirakamaro, bitanga ibisubizo byinshi byo kugabanya ibiro. Guhitamo imiti ikwiye ya GLP-1 biterwa n'intego z'umuntu ku giti cye, amateka y'ubuvuzi, no kwihanganira ingaruka, hamwe n'ubushakashatsi bukomeje butanga uburyo bwo kuvura buhanitse. Soma Ibikurikira

Retatrutid, uburyo bushya bwa GLP-1 bushingiye ku buvuzi, bukomatanya GLP-1, GIP, na glucagon reseptor agonist kugirango butange igisubizo gikomeye cyo kugabanya ibiro no kurwanya isukari mu maraso. Igeragezwa rya Clinical ryerekanye ko rigabanya cyane uburemere bwumubiri nu rwego rwa HbA1c, bigatuma riba uburyo bwiza bwo kuvura ubu umubyibuho ukabije na diyabete yo mu bwoko bwa 2. Nubwo ingaruka zabyo muri rusange zoroheje, ubushakashatsi burakomeje buzakomeza gusuzuma umutekano wigihe kirekire ningirakamaro. Retatrutid ifite amahirwe menshi nkumukino uhindura umukino mugucunga indwara ziterwa na metabolike. Soma Ibikurikira

Retatrutid ikomatanya GLP-1, GIP, na glucagon reseptor agonist kugirango igere ku nzira nyinshi zigira uruhare mu gucunga ibiro no kurwanya glucose yamaraso. Mugutezimbere insuline, kugabanya ubushake bwo kurya, no kongera ibinure byamavuta, Retatrutid itanga igisubizo cyuzuye kubyibushye hamwe na diyabete yo mu bwoko bwa 2. Ibigeragezo byambere byamavuriro byerekana iterambere ryinshi haba kugabanya ibiro no kurwanya glycemic, gushyira Retatrutid nkumuti wibanze. Mugihe ubushakashatsi nubushakashatsi bwamavuriro bugaragaye, bufite ubushobozi bwo guhindura imikorere yindwara ziterwa na metabolike. Soma Ibikurikira

Cocer Peptides ninyongera karemano itanga inyungu nyinshi zubuzima bwiza, harimo kuzamura ingufu, gusana imitsi, ubuzima bwuruhu, nibikorwa byubwenge. Iyi peptide ikora ishyigikira ibikorwa bitandukanye byumubiri, kuva metabolisme yibinure kugeza kongera umubiri. Ugereranije ninyongera gakondo nka vitamine na aside amine, Cocer Peptides itanga inyungu zuzuye hamwe ningaruka nkeya, bigatuma yongerwaho agaciro mubikorwa byose bya buri munsi byubuzima bwiza. Soma Ibikurikira

umuringa-cu ni urwego rugizwe na tripeptide hamwe na ion z'umuringa zingana. umuringa-cu uboneka mumaraso yabantu, amacandwe, ninkari, hamwe nibitekerezo byayo bigenda bigabanuka uko imyaka igenda ishira. Soma Ibikurikira